University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Masters Theses

Graduate School

8-2013

Comparing Stress Responses in Generalized Anxiety Disorder vs.
Non-Clinical Populations: A Cortisol and Alpha-Amylase Study
Dominic Joseph Di Loreto
University of Tennessee - Knoxville, ddilore1@utk.edu

Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes
Part of the Biological Psychology Commons, Clinical Psychology Commons, and the Health
Psychology Commons

Recommended Citation
Di Loreto, Dominic Joseph, "Comparing Stress Responses in Generalized Anxiety Disorder vs. Non-Clinical
Populations: A Cortisol and Alpha-Amylase Study. " Master's Thesis, University of Tennessee, 2013.
https://trace.tennessee.edu/utk_gradthes/2408

This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and
Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE:
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu.

To the Graduate Council:
I am submitting herewith a thesis written by Dominic Joseph Di Loreto entitled "Comparing
Stress Responses in Generalized Anxiety Disorder vs. Non-Clinical Populations: A Cortisol and
Alpha-Amylase Study." I have examined the final electronic copy of this thesis for form and
content and recommend that it be accepted in partial fulfillment of the requirements for the
degree of Master of Arts, with a major in Experimental Psychology.
Debora R. Baldwin, Major Professor
We have read this thesis and recommend its acceptance:
Matthew Cooper, Jacob J. Levy
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

Comparing Stress Responses in Generalized Anxiety Disorder vs.
Non-Clinical Populations: A Cortisol and Alpha-Amylase Study

A Thesis Presented for the
Master of Arts
Degree
University of Tennessee, Knoxville

Dominic Joseph Di Loreto
August 2013

Copyright © 2013 by Dominic Joseph Di Loreto
All rights reserved

ii

Dedication

This thesis is dedicated to my father for never putting a shred of doubt that I could
accomplish anything I desired. He showed me how to work hard and taught me about
reaping what you sew. Working with a new generation of children for the last 7 months has
showed me the value of learning to work hard early in life. It sets a precedent and prepares
one for challenges they face throughout their lifetime. But it’s accomplishing the difficult
tasks and the tasks you don’t want to do that build character and work ethic. He taught me
about the responsibility and pride in accomplishment. And I thank my father for instilling
these qualities in me from a young age by working hard for me. This is my way of showing
him what he has taught me.

iii

Acknowledgements
I would like to show my appreciation for first to Dr. Rex Cannon and Dr. Debora
Baldwin. I worked with both for several years. Although Dr. Cannon was never direct with
his teaching, by forcing me to always research everything and look everything up I learned
the research process. He was extremely influential in my growth as an individual and a
professional. I would also like to thank Dr. Debora Baldwin, who really took me under her
wing when I needed it. She has been extremely patient with me through writing a whole
new thesis and working with me long distance while I have taken on this new job. I
appreciate everything she has taught me and I cannot thank her enough for all the support
she has given me through this abnormal and difficult situation.
I would also like to thank my thesis committee Dr. Debora Baldwin, Dr. Jake Levy
and Dr. Matthew Cooper. Dr. Levy was my advisor as an undergraduate and guided me
through the undergraduate process and has been providing me with great advice for the
past several years. Dr. Cooper taught my two favorite classes in my college career thus far.
I have a tremendous amount of respect for him and his knowledge of neuroscience. I am
honored to have all three serve on my committee
And again, I would like to thank my family for everything they have done for me.
They have always given me the resources I needed to succeed and have been supportive
and motivational along the way. My mother has always helped me in any way she could
and my sister always kept me motivated through sibling rivalry. I always wished I could
have been a double major also.

iv

Abstract
Debilitating anxiety affects 6.8 million Americans. Cortisol is an established measure of
the stress response which reflects the hypothalamic-pituitary-adrenal (HPA) axis activity.
However, salivary alpha-amylase (sAA) is a relatively new measure of the stress response, and it
reflects the sympathetic-adrenal-medullary pathway (SAM pathway) activity. Our aim was to
compare these two aspects of the stress response in a Generalized Anxiety Disorder (GAD) and a
non-clinical population under a stressful stimulus (Knee replacement surgery video). To our
knowledge this is the first time anyone has looked at both sAA and cortisol together with respect
to GAD. We hypothesized that both cortisol and sAA levels would raise from pre-stimulus to
post-stimulus, but not in concert. Forty-six college students were assessed for GADs and
randomly assigned to watch a stressful or neutral video. Saliva samples were taken at the
beginning of the study, immediately after the video, and 30 minutes after the video. Participants
were also given the Taylor Manifest Anxiety Scale TMAS and Beck Anxiety Inventory BAI as
measures of state and trait anxiety. There was a significant difference between GAD and nonclinical groups for the TMAS and a significant group by condition interaction for baseline
cortisol. Our GAD, stress sub-group had a significantly raised baseline cortisol level. Although
the GAD and Non-clinical groups did not differ significantly with regard to baseline cortisol
levels, it was in the hypothesized direction. Moreover, baseline cortisol levels were inversely
related to baseline sAA levels. The findings suggest that cortisol and sAA show contrary diurnal
responses.
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Section 1: Introduction
According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV, 1994),
anxiety disorders include panic disorder, agoraphobia, post-traumatic stress disorder (PTSD),
obsessive-compulsive disorder (OCD), social anxiety disorder (social phobia), and generalized
anxiety disorder (GAD). Estimates indicate that 6.8 million Americans exhibit debilitating
anxiety (Kessler, Chiu, Demler, Walters, 2005). The common feature within anxiety disorders is
excessive, irrational fear and avoidance of anxiety triggers. The impact of pathological anxiety
extends to impaired workplace performance, hefty economic costs of up to 40 billion dollars
each year (Greenberg, Sisitsky, Kessler, Finkelstein, Berndt, Davidson, 1999), greater risk of
cardiovascular and cerebral vascular disease (Vogelzangs, Seldenrijk, Beekman, de Jonge,
Penninx, 2010), and associations with mild cognitive impairment (Devier, Pelton, Tabert, Liu,
Cuasay, Stern, Devanand, 2009). Thus, knowledge pertaining to this construct is impactful in a
multitude of ways.
Anxiety has been conceptualized in many ways, consisting of several domains, making it
a difficult topic to easily summarize or explain. According to Speilberger (1966), there are two
forms of anxiety. The first form is state anxiety, which reflects a transitory emotional state or a
condition that is characterized by subjective, consciously perceived feelings of tension and
apprehension, and heightened autonomic nervous system activity. State anxiety is a variable state
and may fluctuate. The second form is trait anxiety which refers to a general tendency to respond
with anxiety to perceived threats in the environment, and it is a relatively stable characteristic of
an individual. An individual with higher trait anxiety feels more threats in many situations than
someone with low trait anxiety (Horikawa & Yagi, 2012).
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Recent research has also categorized anxiety with fear as a physiological threat response.
Fear is a phasic response to an immediate threat and anxiety is a prolonged worrisome state to
some future threat (Walker, Toufexis, Davis, 2003). Barlow & Lehman, (1996) described anxiety
as a future-oriented cognitive-affective-somatic state; the prominent feature being ‘‘a sense of
uncontrollability focused on possible future threat, danger, or other upcoming, potentially
negative events.’’ Paulus, Feinstein, Simmons, & Stein, (2004) propose anxiety as a
manifestation of cognitions related to the self. What unites these theories is that in one way or
another anxiety elicits a physical stress response.
Anxiety is the body’s natural reaction to real or perceived danger. The body then goes
through a series of chemical and physical changes, called stress responses, to prepare for the
danger. There are two stress responses in the body. When the body is presented with an
immediate threat or danger, the sympathetic-adrenal-medullary pathway (SAM) is activated.
This sympathetic nervous system pathway starts with biosynthesis in the adrenal medulla and
releases several catacholomines including epinephrine, norepinephrine, and dopamine. This is
commonly referred to as the fight or flight response. The second stress response pathway is the
slower moving hypothalamic-pituitary-adrenal (HPA) axis. When a threat or danger is perceived,
corticotrophin releasing factor (CRF) is produced in the hypothalamus and sent to the anterior
pituitary gland in the brain. The pituitary gland then produces adrenocorticotropic hormone
(ACTH ) which is sent to the adrenal cortex where biosynthesis in the adrenal cortex produces
the hormone cortisol. It allows the body to prolong the fight or flight response.
We aim to investigate possible differences between the two stress response systems in a
GAD sample compared to a control sample. Throughout this thesis, we will review state vs. trait
anxiety, several theories surrounding the concept of anxiety, and the endocrinology links to
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stress. In the current study we will examine the neuroendocrinology of anxiety in a GAD
populations compared to a normal population using salivary cortisol to test the response of the
HPA axis and alpha amylase (sAA) to measure the (SAM) system under a stressful stimulus.
Trait v. State Anxiety
State and trait anxiety are commonly accepted as separate forms of anxiety. State and trait
anxiety are distinctive in that state anxiety is classified as a temporary state of worry and trait
anxiety is an enduring predisposition to anxiety that is consistent across situations (Spielberger,
1985). Trait and state anxiety have both been proposed to be uni-dimensional, bimodal, and
multidimensional constructs (Davidson & Schwartz, 1976; Everitt, 1981; Spielberger, 1985). The
uni-dimensional view is the separation of trait and state as single entities with state anxiety being
the actual physical arousal to a stimulus and trait being the predisposition for arousal
(Spielberger, 1985). The multidimensional view breaks state anxiety into possessing somatic and
cognitive components (Davidson & Schwartz, 1976) and trait anxiety into social, ambiguous,
danger, and daily routine components (Endler & Kocovski, 2001).
Trait anxiety comprises the tendency to respond anxiously to a wide variety of unspecific
stressors (Spielberger, 1972). Interestingly, Wilkin, Smith, Tola, Mann, (2000) reported that low
trait anxious subjects showed a greater stress response than high trait subjects. The authors
explained this in several ways. First, the high trait anxious group could have higher baselines of
physiological stress; thus, the presentation of the stimulus pushed them over the inverted “U”
arousal curve. The authors further explained, low trait anxious individual showed a linear trend
of arousal up one side of the inverted “U”. In addition, trait anxiety has been shown to be highly
consistent with cognitive and somatic state anxiety ratings (Gould, Petlichkoff, Weinberg, 1984;
Hanton, Mellalieu, Hall, 2002). Additionally, trait anxiety and subjective autonomic response
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reports have shown a positive correlation with basal cortisol levels but not cortisol elevation to a
social stress test in 20 healthy young men (Takahashi, Ikeda, Ishikawa, Kitamura, Tsukasaki,
Nakama, Kameda, 2005).
Neurophysiologically, healthy subjects who scored high on trait anxiety have smaller
prefrontal cortical volume (Spampinato, Wood, De Simone, Grafman, 2009) and less
connectivity between the prefrontal cortex and the amygdala (Kim & Whalen, 2009). Paulus,
Feinstein, Simmons, & Stein, (2004) however, found that activation of the anterior cingulated
cortex and medial prefrontal cortex were significantly higher in high trait-anxiety subjects and
was correlated with trait but not state anxiety. The prefrontal cortex has been shown to inhibit the
HPA axis (Jahn, Fox, Abercrombie, Shelton, Oakes, Davidson, Kalin, 2010), and therefore may
play a role in the dysfunction of the chemical stress response related to anxiety. Dysfunctions in
the chemical stress response have been reported to correlate with generalized anxiety disorder.
For example, Elevated cortisol levels have also been found in children ages 8 - 13 with anxiety
disorders (McBurnett, Lahey, Frick, Risch, Loeber, Hart, Hanson, 1991) and older adults with
GAD (Mantella, Butters, Amico, Mazumdar, Rollman, Begley, Reynolds, Lenze, 2008).
It is unclear in the literature how the HPA axis and SAM pathway work with respect to
state or trait anxiety. However, this study will provide data in which to start differentiating
between normal and pathological anxiety in relation to the HPA axis and SAM pathway.
Theories of Anxiety
Barlow’s Anxious Apprehension Model
David Barlow proposed a bidirectional model of arousal and attention. He posits that
negative affect causes a shift in attention to self-evaluative focus, which results in further
increases of arousal and narrows attention to potential threats. This creates a constant state of
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worry characterized by avoidance behaviors. He suggests that people tend to explain their
arousal in terms of their negative view of the world. So as arousal rises, the more negative the
world appears creating a negative feedback loop (Barlow, 1988).
Eysenck’s Interversion/Extroversion
Eysenck proposed arousal on a continuum with introversion and extroversion at the polar
ends. He argues that introverts are already highly aroused and aim to maintain or lower there
arousal via avoidance of social situations. Extroverts are low in arousal and aim to increase their
arousal level by seeking social stimulation. Eysenck proposes introversion and extraversion are
located on a theoretical horizontal axis. In addition, a theoretical vertical axis contains
neuroticism and stability at its polar ends. Neurotic individuals would be characterized by high
autonomic function, while stable individuals would be characterized by low autonomic function
(Eysenck, 1967). Grey (1982) then proposed an additional axis running from the
introversion/neuroticism quartile through to the extroversion/stability quartile, which indicates
types of symptomatic behavior. He believes, if an individual is too far in the introvert/neurotic
quartile this leads to anxiety and too far in the extravert/stable quartile leads to impulsive
behavior.
Aversive Conditioning
Recent research has focused on the aversive conditioning of an intertwined anxiety/fear
network. In aversive conditioning, fear is described as a phasic response to imminent threat
(Walker et al. 2003) typified by a surge of physiological arousal as in an alarm reaction
(flight/fight) of the autonomic nervous system (Blanchard Sakai, McEwen, Weiss, Blanchard,
1993). Alternatively, anxiety is a sustained response to temporarily uncertain danger (Walker et
al., 2003), which may be distal and distinguished via heightened apprehension and vigilance

5

(Blanchard et al., 1993). Behaviorally, anxiety is associated with avoidance and increased
overall sensory sensitivity (Baas, Nugent, Lissek, Pine, Grillon, 2004; Cornwell, Baas, Johnson,
Holroyd, Carver, Lissek, Grillion, 2007) commonly derived from aversive conditioning.
Aversive conditioning occurs when a discrete, conditioned stimulus (CS), such as a light,
is paired with an aversive unconditioned stimulus (e.g., a shock). Fear will develop to the
discrete cue and to the environmental context (LeDoux, 1996). For example, the repeated pairing
of a rabbit with an electric shock may cause the rabbit to become an aversive stimulus for that
individual.
Eventually, this notion led to an unfolding of several other theories. The Preparedness
Theory (Seligman, 1971) results from Pavlovian conditioning, but postulates that some stimuli
are naturally dispositioned for aversive conditioning. These neutral stimuli are graded along a
continuum of biological predispositions for a fear condition. These predispositions extend from a
pre-technological age that may include commonly feared stimuli such as snakes or spiders.
Within this theory, these commonly feared stimuli should be conditioned more rapidly, be more
resistant to extinction, and be more resistant to cognitive influences. The alternative to the
Preparedness Theory is Equipotentiality Hypothesis, which assumes that all stimuli have equal
potential to be fear eliciting. The equipotentiality theory was confirmed by McNally & Reiss
(1982) when they used both snakes and flowers as unconditioned stimuli. They found that both
predispositioned stimuli, such as a snake, and neutral stimuli, such as a flower, have potential for
aversive conditioning.
Multi-Network Dysfunction
Sylvester, Corbetta, Raichle, Rodebaugh, Schlagger, Sheline, Zorumski, Lenze, (2012)
reject the notion of a single circuit, such as the fear/anxiety circuit. Contrarily, they propose an
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individual’s fear or anxiety behavior may be the product of several dysregulated circuits. This
theory is based on the idea that the study of functional networks will revolutionize our
perspectives of psychological disorders. Findings suggest that psychological disorders may
merely be disruptions in differential combinations of networks. Their research reveals for
anxiety, dysregulation lies in the overactive cingulo-opercular and ventral attention network and
underactive default mode in the frontal parietal network. The cingulo-operular network includes
the dorsal AC, anterior thalamus, anterior PFC and the insula; it is important for cognitive
control of error and conflict detection (Sylvester et al., 2012). Over activity in this network may
establish rumination involving errors or conflict. The ventral attention system includes the
ventrolateral PFC and temporal parietal junction and is involved in directing attention to newly
appearing stimuli (Sylvester et al., 2012). Excessive activity of this network may cause an
individual to focus on unnecessary stimuli.
Anxiety Sensitivity
The anxiety sensitivity construct has a similar concept to trait anxiety, with the
distinguishing feature being “fear of fear” (Reiss & McNally, 1985). It is described as “an
individual difference variable consisting of beliefs about the experience of anxiety/fear which
causes illness, embarrassment or additional anxiety.” For example, when the doctor tells an
individual to avoid excitement in order to minimize the risk of a heart attack, the advice should
increase the patients’ motivation to avoid exciting stimuli. However, this advice increases the
patients anxiety without experiencing a heart attack themselves. In fact, one criterion for panic
disorder is fear of having another panic attack (DSM-IV, 1994). This possibly contributes further
to anxiety disorders. It has been shown that anxiety sensitivity, as measured by the Anxiety
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Sensitivity Index (ASI), is higher in patients with anxiety disorders and extremely higher in
individuals with agoraphobia (Reiss and McNally, 1986).
Attentional Control Theory
A meta-analysis by Bar-Haim, Lamy, Pergamin, Bakermans-Kranenburg, van IJzendoorn
(2007) demonstrates that anxious individuals display an attentional bias towards threatening
sources of information, and this effect is less consistent or typically not observed in non-anxious
individuals. Eysenck and colleagues (Derakshan and Eysenck, 2009; Eysenck, Derakshan,
Santos, Calvo, 2007) propose attentional control theory (ACT). This theory states that individual
differences in trait anxiety are embedded in higher order cognitive function. High anxious
individuals have an inclination to suppress their behavior in risk taking conditions. However,
behavioral suppression is compensated by increased attention to external stimuli. Therefore
anxiety is a bias toward the stimulus driven attention system over a goal directed attention
system making task irrelevant stimuli become more intrusive than it does in low trait anxious
individuals. Persons with high anxiety try to control their environment, as much as possible.
Moreover, their attention to the environment and their own behavior is constantly maintained at a
higher level. This attentional deficit requires them to recruit additional cognitive resources using
more neuronal power than should be necessary; thus, leaving fewer resources for other cognitive
processes. Neurophysiology of attentional control includes the lateral prefrontal cortex and the
anterior cingulate cortex, particularly in the allocation of attentional resources and executive
function (Miller & Cohen, 2001). These findings suggest that anxiety interferes with recruitment
of prefrontal regions required for attentional control.

8

Negativity Bias
Likewise, in cognitive psychology, preferential attention to negatively valenced stimuli is
interpreted as negativity bias (Ito, Larsen, Smith, Cacioppo, 1998). Excessive arousal due to
trauma or stress may result in permanent brain changes that exacerbate a bias towards the
expectation of threat. Beck (1976) highlighted how negativity biases are central to the
development and maintenance of depression and anxiety. Biases towards fear stimuli in
depression and anxiety have been observed in cognitive tasks that manipulate both nonconscious
and conscious processing (Bradley Mogg, Millar, White, 1995). Anxious (GAD) and normal
participants carried out a modified Stroop color-naming task with anxiety- and depressionrelated words. Compared with controls, the GAD subgroup showed slower color naming for
negative than neutral words. In addition, within the anxious group, patients with GAD without
concurrent depression showed more color-naming interference for anxiety words than neutral
words than participants with comorbid GAD and depression. The neurocircuitry of negativity
bias may be associated with anticipation of a fear cue (Carretié, Mercado, Hinojosa, Jose,
Martin-Loeches, Sotillo, 2004). This unconscious processing of anxiety produces hyperactivation
in the amygdala, mPFC and AC (Williams & Gordon, 2007).
Anxiety is an interesting construct that has derived many theories regarding its
functionality and physiology. Regardless of the theoretical background used to explain anxiety,
millions of people suffer from this disorder. Illumination on the physiological response to a
given stressor may facilitate better understanding and lead to more effective treatments for
individuals who suffer with GAD in particular.
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Generalized Anxiety Disorder
Generalized anxiety disorder is characterized by excessive diffuse anxiety and worry that is
difficult to control and debilitating to daily life (American Psychology Association, 2000).
GAD’s listed features in the DSM-IV are muscle tension, trembling, twitching, feeling shaky,
and muscle aches/soreness. It also includes hypervigilance and hyper arousal comprising of an
accelerated heart rate, shortness of breath and dizziness. Somatic symptoms such as sweating,
nausea, diarrhea, and exaggerated startle response characterize it as well. GAD has a prevalence
rate of 3% in one year and 5% in the lifetime. It frequently occurs with other mood disorders,
anxiety disorders, and substance abuse disorders (APA, 2000). Different cultures seem to express
GAD differently; somatic symptoms are more of a focus in some, while cognitive symptoms are
weighted more heavily in others (APA, 2000).
A reduction of cerebral blood flow (CBF) has been found to be a customary characteristic
of GAD (Mathews & Wilson, 1987; Nutt, 2001). In negative emotional processing, greater
amygdala and insula activity was found in GAD compared to controls (Etkin & Wager 2007).
However, some studies have not found exaggerated amygdala response in GAD (Blair, 2008).
With regard to prefrontal activity, Monk, Nelson, McClure, Mogg, Bradley, Leibenluft, Blair,
Chen, Charney, Ernst, Pine, (2006) found greater fMRI BOLD responses in the right
ventrolateral prefrontal cortex to emotionally adverse stimuli in GAD compared to healthy
controls. Many of these regions have been implicated in control of the HPA axis.
Stress Response Systems:
Stress responses are related to behavior, cognition, and psychopathology (Fortunato,
Dribin, Granger, Bus, 2008). Both stress responses evoke a chain of neuroendocrine reactions. A
variety of stressful events cause an increase in epinephrine in several brain regions including the
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hypothalamus, amygdala, and locus coeruleus in a rat model (Tanaka, Yoshida, Emoto, Ishii,
2000). Another neurotransmitter, serotonin has been shown to be involved in the HPA axis
(Hanley & Van de Karr, 2003). But the most predictable anxiolytic effects seem to be linked to
the GABAergic system, specifically in the benzodiazepine receptors (Bailey & Nutt, 2008;
Hoehn-Saric, 1982). The autonomic nervous system has been shown to play a role in stress
related disorders such as depression and anxiety (Careny, Freedland, Weith, 2007; Guinjoan,
Bernabo, Cardinali, 1995; Vaith, Lewis, Linares, Barnes, Raskind, Villacres, Murburg, Ashleigh,
Castillo, Peskind, 1994; van Veen et al., 2008).
Two of the main physiological systems activated by stress are the SAM pathway (which is
the short term “flight or flight” indicator of stress) and the HPA axis (which is more of a long
term hormonal measure of stress). The SAM pathway starts with the hypothalamus stimulating
the adrenal medulla. This begins the autonomic nervous system response by secreting the
hormone adrenaline. Adrenaline stimulates the sympathetic nervous system (SNS) “fight or
flight” response which includes decreased digestion, increased sweating blood pressure, and
innervates the salivary glands. The SAM pathway and the HPA axis, together, play a role in
homeostasis through catecholamine and glucocorticoid interaction (Engert, Efanov, Duchesne,
Corbo, Pruessner, 2011).
SAM Pathway, Alpha-Amylase, and Stress
Under activation of the SNS and the SAM pathway, alpha-amylase (alpha-1, 4-alpha-Dglucan 4-glucanohydrolase) is one of the major protein components produced in saliva,
accounting for 40-50% of gland produced protein (Zakowski & Bruns, 1985). It is produced via
alpha and beta adrenergic mechanisms (Nater & Rohleder, 2009) in the epithelial acinar cells of
the exocrine salivary glands (Baum, 1993). Its main function is the enzymatic digestion of
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carbohydrates (Baum, 1993), but it is also important for mucosal immunity in the oral cavity, as
it inhibits the adherence and growth of bacteria (Rohleder & Nater, 2009). Because sAA is
produced with the saliva, it may be a better salivary marker of stress compared to cortisol. It is an
active measurement, as opposed to cortisol which is passively transported by saliva (Baum,
1993).
Recently, the use of alpha-amylase (sAA) as an indicator of stress has become widely
popular (Nater, Rohleder, Gaab, 2005). It is sensitive to physical and psycholological stress
(DeCaro, 2008; Granger, Kivlighan, el-Sheikh, Gordis, Stroud, 2007; Nater & Rohleder, 2009;
Strahler, Berndt, Kirschbaum, Rohleder, 2010). In addition, it has been shown to be an accurate
indicator of autonomic function (Ehlert, Erni, Hebisch, Nater, 2006) and has been shown to
correlate with norepinephrine in the blood under exercise and psychosocial stress (Chatterton,
Vogelsong, Lu, Ellman, Hudgens, 1996). Moreover, it has been shown to be suppressed by betaadrenorecepter blockade (van Stergen, Rohleder, Everaerd, Wolf, 2006). It tends to be elevated
in pathological populations including generalized social anxiety disorder (van Veen et al., 2008),
schizophrenia (Inagaki et al., 2010), and borderline personality disorder (Nater Chrousos, Kino,
2010).
In a study of the genetics of sAA, correlations were larger for monozygotic than dizygotic
twins, although both groups had large correlations. Out et al. (2011) concluded that there is
evidence for one common genetic factor that accounted for 51% of the variance of sAA levels at
baseline and between 56%and 62% during a stressful baby cry paradigm. It has been shown that
age has no effect of sAA levels (Aguirre, Levine, Cohen, Tabak, 1987; Salvolini, Mazzanti,
Martarelli, Di Gorgio, Fratto, Curatola, 1999), but more recent evidence has suggested that basal
sAA levels increase with age (Strahler, Berndt, Kirschbaum, Rohleder, 2010).
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Almost every physiological system has some sort of circadian rhythm. Disruptions in this
biological rhythm have been associated with several psychological and physical disorders
including renal disease (Kock et al., 2009), depression (Tan et al., 2007), and post traumatic
stress disorder (Wessa et al., 2006). Both Alpha amylase (sAA) and cortisol follow diurnal
rhythms. The diurnal pattern of sAA activity decreases sixty-minutes after waking and increases
at throughout the day (Natar, Rohleder, Schlotz, Ehlert, Kirschbaum, 2007) while cortisol is
highest in the morning then decreases throughout the day. sAA responds faster to acute
challenges and has a lower activation threshold than cortisol (Gordis et al., 2006). Few studies
have compared the differences between sAA and cortisol levels as a function of pathological
anxiety. We examined both (diagnostic classification and pathways) in this study.
HPA Axis and Stress
Secretion of cortisol, through the HPA axis, is a necessary physiological response to
emotional and physical stress. It promotes survival in life threatening situations. Salivary
cortisol levels are highly positively correlated with serum levels of cortisol (r>.9) (Umeda,
Hiramatsu, Iwaoka, Shimada, Miura, & Sato, 1981). Salivary cortisol is actually advantageous to
serum cortisol due to the fact that only free hormone fraction will be determined, removing the
buffer of other influences such as binding proteins (Foley & Kirschbaum, 2010; Follenius &
Brandenberger, 1986). Moreover, it is a non-invasive measure, which reduces potential “carryover” effects that may be associated with more invasive methods (plasma cortisol).
Stimulation of the paraventricular nucleus of the hypothalamus results in activation of
the HPA axis producing ACTH from the pituitary gland. ACTH stimulates the adrenal cortex
and produces cortisol, which enables the body to maintain steady supplies of blood sugar.
Adequate and steady blood sugar levels help a person cope with prolonged exposure to a stressor
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by ensuring it has enough energy to meet the demand and help the body to return to homeostasis.
It takes about 30 minutes to peak, although it shows vast variation in latency to peak within
people (Foley & Kirschbaum, 2010). The PFC, hippocampus, and parahippocampal gyrus have
been implicated in the modulation of the HPA axis function by acting as a site for
glucocorticoids to exert negative feedback (Diorio, Viau, & Meaney, 1993; Hurley-Guis &
Neafsey, 1986; Jahn et al., 2010; Pruessner, Dedovic, Pruessner, Lord, Buss, Collins, Dagher,
Lupien, 2010; Sapolsky, Romero, Munck,2000).
Chronic psychological distress can lead to hyperactivity of the HPA axis (Baldwin,
Cannon, Fischer, Kivisto, 2008; Mantella et al., 2008; O’Brien, Lloyd, McKeith, Gholkar,
Ferrier, 2006) and increase cortisol activity at these sites. This can cause damage to the
hippocampal neurons (Sapolsky et al., 2000), which results in deleterious effects on memory
and executive functions (Bremner, Vythilingam, Vermetten, Anderson, Newcomer, Charney,
2004; Li, Cherrier, Tsuang, Petrie, Colasurdo, Craft, Schellenburg, Peskind, Raskind, Wilkinson,
2006; Lupien, Lecours, Lussier, Schwartz, Nair, Meaney, 1994; Mantella et al., 2008).
Additionally, aging alters the basal cortisol rhythmicity and possibly diminishes the ability to
regulate the HPA axis. (Van Cauter, Leproult, Kupfer, 1996; Lupien et al., 1994).
A relationship has also been found between anxiety and cortisol levels. For example,
Vreeburg, Zitman, van Pelt, Derijk, Verhagen, van Dyke, Hoogendijk, Smith, & Penninx (2010)
conducted a cortisol investigation in populations with and without anxiety disorders. They found
a significant positive association with all anxiety disorders and morning cortisol. This included
panic disorder, agoraphobia, major depressive disorder, and generalized anxiety disorder.
However the largest contributors to the correlation were panic disorder with agoraphobia and
anxiety disorders comorbid with depression. However, Vedhara, Miles, Bennett, Plummer,
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Tallon, Brooks, Gale, Munnoch, Schreiber-Kounine, Fowler, Lightman, Sammon, Rayter, &
Farndon (2003) did not find a significant correlation between stress, anxiety and absolute
cortisol levels in 54 women attending a diagnostic breast clinic. However they did find a nonlinear relation between time of day and cortisol levels. More specifically, cortisol levels
decreased as the day progressed. Finally, studies show that cortisol levels often do not correlate
with alpha amylase during stress (Chatterton et al., 1996; Nater & Rohleder, 2009; Schenkels,
Veerman, Nieuw Amerongen, 2005, Strahler et al., 2010) reaffirming their activity due to two
different stress systems.
Objectives:
van Veen et al. (2008) examined 43 general social anxiety disorder participants regarding
HPA axis and ANS functioning. They found elevated levels of basal sAA and diurnal sAA, but
not cortisol in participants with generalized social anxiety. Similarly, Takai et al. (2004)
examined the effects of a psychosocial stressor and soother on salivary cortisol and sAA levels in
young adults and compared them to the trait version of the State-Trait Anxiety Inventory (STAI).
The participants provided samples every three minutes throughout a stressing and/or soothing
video. sAA levels rose at the start of the stressor and fell to baseline at the end. Cortisol levels
rose to a lesser extent and remained elevated for a longer period of time than the sAA. Also, sAA
levels, but not cortisol levels, correlated with the trait version of the STAI. The question remains
whether there are differences in resting and response conditions in the SAM pathway and HPA
axis activity in generalized anxiety compared to non-clinical populations.
To our knowledge, we are the first to examine sAA and cortisol response in a GAD
population in the same study. The objective of the current study is to examine the
neuroendocrine measures of stress in non clinical populations compared to a generalized anxiety
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disorder population using cortisol as a measure of the HPA axis and sAA as a measure of the
SNS. We will evoke stress in the participants by using a six-minute knee replacement surgery
video clip. The endocrine measures will then be compared with the Beck Anxiety Inventory
(BAI), a diagnostic inventory measuring state anxiety, and the Taylor Manifest Anxiety Scale
(TMAS), a scale measuring trait anxiety.
Hypothesis
We hypothesize that the GAD group will have greater basal cortisol than the nonclinical group, but there will be no differences between groups for basal sAA
levels.
We hypothesized that baseline cortisol and sAA will be positively related
irrespective of group.
We hypothesized that there will be a greater increase in cortisol and sAA levels
from pretest to posttest stimulus in the clinical group compared to the normal
population.
We hypothesized that high trait anxiety as measured by the TMAS will be
associated with higher basal cortisol levels, but not sAA levels.
We hypothesized that higher two week state anxiety scores as measured by the
BAI will be associated with higher basal cortisol levels, but not sAA levels.
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Section 2: Methods
Participants
The study included 46 university students between the ages of 18 and 25 divided
(M=20.609, SD =1.9262) into two groups of a GAD (n=22; M=20.542, SD =2.1865) and a
normal population (n=24; M=20.682, SD =1.6442). The sample was 76% female (n=36) and
83% Caucasian (n=38), 13% African American (n=6), 3% Hispanic (n=2). The GAD participants
had a diagnosis of GAD as confirmed by the Miniature International Neuropsychiatric Interview
(M.I.N.I.) or a BAI score of >15. All subjects were recruited from the University of Tennessee
Knoxville’s Human Participation in Research pool. The students were offered extra credit for
their participation. All participants completed an Informed Consent document (see appendix) and
held the right to drop out of the study at any time.
Materials:
Miniature International Neuropsychiatric Interview All participants underwent a minimally intrusive standardized clinical interview at the
start of this study. The clinical interview took approximately 10 minutes to complete and was
completed after the first cortisol sample and before the video. This study used the M.I.N.I.,
which follows DSM-IV-TR (2004) AXIS I diagnostic criteria for relevant clinical interviewing
process inquiring about current psychopathological diagnosis, present symptoms (i.e., within past
two-weeks) and life-time history of psychopathological episodes (i.e., initial onset and
reoccurrence). Confirmation of the diagnostic outcome was supervised by a licensed counseling
psychologist.
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Knee Replacement Surgery Video –
The video is a YouTube video showing a knee replacement surgery. It is a six minute
video clip and was shown on a computer screen in the Biopsychology Laboratory at the
University of Tennessee. Viewing videos of surgery is a widely used stimulus that activates
hormonal stress response (Bosch et al., 2003; Takai et al., 2004; Takai, Yamaguchi, Aragaki,
Eto, Uchihashi, Nishikawa, 2007).
Beck Anxiety Inventory (BAI) –
The BAI is a state dependent measure of anxiety (Beck, 1993). Engagement in the BAI
places the participant in the anxiety-reminiscent context, therefore eliciting a state-dependent
anxiety response. It is a diagnostic tool; therefore, scores on the BAI are directly related to
participant symptoms. It is also used to assess clinical treatment. The BAI consists of twenty-one
questions expressed as common symptoms of anxiety (e.g. numbness and tingling, sweating not
due to heat, and fear of the worst happening). It is designed for an age range of 17–80 years old.
Each question has the same set of four possible answer choices, which are arranged in columns
and are answered by marking the appropriate one with a cross. These are: Not at all (0 points),
Mildly: It did not bother me much. (1 point), Moderately: It was very unpleasant, but I could
stand it. (2 points), Severely: I could barely stand it. (3 points). The BAI has a maximum score of
63. It is rated such that: 0-7: minimal level of anxiety, 8-15: mild anxiety, 16-25: moderate
anxiety, 26-63: severe anxiety. The BAI is psychometrically sound as indicated by internal
consistency ranges from .92 to .94 for adults and test-retest (one week interval) reliability is .75
(Beck, 1993).
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Taylor Manifest Anxiety ScaleThe TMAS is a 50 item scale used as a general indicator of trait anxiety (Taylor, 1953).
True-false responses are used for each item, and the responses indicating anxiety are summed.
The scores range from 0 to 50 with higher scores indicating greater trait anxiety. It is up to the
discretion of the investigator to decide where they fit in the “manifest anxiety” interpretation.
Items judged by clinicians as being indicative of manifest anxiety were selected from the
Minnesota Multiphasic Personality Inventory. Correlations of 0.72 and 0.75 were reported
between the TMAS and Evsenck’s measure of neuroticism in two samples. High correlations of
0.81 and 0.92 were reported between the TMAS and the psycho-asthenia scale of the MMPI and
a low of 0.64 with the Beck Depression Inventory. For the original 50-item version, retest
correlations of 0.89, 0.82, and 0.81 over intervals of three weeks, five months and nine to 17
months (Taylor, 1953).
Saliva SamplingParticipants were seated and instructed to expectorate into a sanitized 50 mL collection tube once
per minute over a three minute period (Navazesh, 1993). Once collected, saliva samples were
centrifuged for ten minutes, alloquated in microtubes (two per sample), and stored at -70 degrees
Celsius for subsequent analysis. We also obtained medications, time of day, and data relative to
menstrual cycle for female participants among other variables as indicated by (Kudielka,
Hellhammer, & Wust, 2009). We asked that participants not smoke, eat, or exercise within an
hour of sampling (Salimetrics Inc.). We collected one saliva sample prior to the stressful video,
and this sample was the baseline for both the cortisol and sAA measures. We collected a second
sample right after the video which corresponds to the expected peak of the sAA response and a
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third sample 20 minutes after the second sample which corresponds to the expected peak of 30
minutes for the cortisol response.
Analyzing sAASupernatants were analyzed for total sAA concentration using the Salivary AlphaAmylase Kit (Salimetrics Inc, PA). This method utilizes a chromagnic substrate, 2-cloro-pnitrophenol, linked with maltotriose (Wallenfells et al., 1978) the enzyme action of the sAA on
this substrate yields 2-chloro-p-ntrophrenal, which can be spectrophotometrically measured at
405nm. The amount of sAA activity present in the sample is directly proportional to the increase
in absorbance at 405nm. Assay concentrations are given in opitical density and were converted
to U/mL and range from 3.1 – 423.1 U/mL. The Assay has been shown to be test-retest reliable
for high, medium, and low with a coefficient of variation of 2.5%, 6.7%, and 7.2% respectively
(n=10) (Salimetrics Inc., PA). Samples were divided randomly and equally between two plates.
Analyzing CortisolSupernatants were analyzed for total cortisol concentration using the High Sensitivity
Salivary Cortisol Enzyme Immunoassay Kit (Salimetrics Inc., PA). The bound cortisol
peroxidase is measured by the reaction of peroxidase enzyme on the substrate
tetramathylbenzidine (TMB). Assay concentrations are given in optical density that must be
converted to μg/dL, and the assay can detect cortisol levels from 0.003 to 3.0 μg/dL. Optical
density is read on a standard plate reader at 450nm. Samples were divided randomly among 4
plates.
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ProcedureThe subjects signed up for a designated time on the University of Tennessee Human
Participation in Research pool (HPR) and signed an Informed Consent Statement. We collected
the first saliva sample from each participant and then administered the (M.I.N.I.). Subjects were
then seated in front of a computer monitor where they were shown a 6-minute video clip of a
knee replacement surgery or travel documentary on the Blue Mountains of Australia. The latter
video acted as a non-stressed control condition. . This provided an appropriate mechanism for
examining activation or non activation of the HPA axis and SAM pathway. Immediately, after
the video we collected the second saliva sample and collected the third saliva sample 20 minutes
after the second. Next, the participants filled out the BAI and TMAS to assess their state and trait
anxiety levels respectively. It is important to do these after the post cortisol sample to avoid any
confounds in the stressor. Participants held the right to drop from the study at any time.
Data Analysis
The study design is a 2 x 2 x 2 x 3(Group [GAD vs Control] x Condition [stress vs no
stress] x Stress Measure [sAA vs Cortisol] x Time [T1, T2, T3]). All data analyses were
performed in SPSS 19 32-bit statistical mining program. We used an alpha level of .05 for all
statistical tests. First a data transformation was performed creating difference time series data for
cortisol and sAA measures which entered the data as cort2-1, cort3-1, sAA 2-1, sAA3-1. In order
to determine differences between groups and stress conditions, several multivariate generalized
linear analyses were performed on the dependent measures (physiological and self-report
variables). The fixed factors were the group (GAD vs Control) and the condition (experimental
vs control). A bivariate correlation was performed between BAI, TMAS, Cort T1, and sAA T1.
Means and standard deviation for the study variables are presented in Table 1.
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Section 3: Results
Cortisol
Figure 1 presents the cortisol results as a function of group, condition, and time. It
was hypothesized that basal salivary cortisol levels would be elevated in the GAD group
compared to the non-clinical group. The analysis revealed a marginally significant difference
between groups for baseline cortisol levels [F (1,46) = 2.875, p=.098]. There was a significant
group by condition interaction [F (1,46) = 4.351, p=.044]. This means that the non-clinical
(M=.385, SD= .181) and GAD groups (M=.531, SD=.298) had no difference in baseline cortisol,
but the GAD, stress condition (M=.645, SD=.328) had significantly elevated baseline cortisol
level before seeing the video (see Figure 3). We hypothesized there would be an increased
cortisol response in the GAD at T2 (M=.468, SD=.244) and T3 (M=.396, SD=.209) compared to
the non-clinical group at T2 (M=.605, SD.463) and T3 (M=.540, SD=.540). There were no
significant differences between groups in the cortisol response for T2 [F (1,46) = .286, p=.596]
and T3 [F (1,46) = .149, p=.702] (see Table 5). Moreover, there were no significant interactions (
p > .05). However, there was a significant difference is cortisol response from T1 to T2 between
the stress (M=.146, SD=.585) and non- stress conditions (M=-.179, SD=.454), [F (1,46) = 4.519,
p=.04]. This suggests that the surgical video elicited a greater neuroendocrine stress response
compared to the control video.
Correlational data are presented in Table 4. We hypothesized that the BAI would be
positively associated with baseline cortisol levels. The analysis yielded no significant correlation
[r (44) = .07, p=.46] between baseline cortisol and the BAI. We hypothesized that trait anxiety,
as measured by the TMAS, would be positively correlated with baseline salivary cortisol. The
analysis yielded no significant correlation between the TMAS and baseline cortisol levels [r
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(1,46) = .185, p = .109]. Finally, we hypothesized a positive correlation between cortisol levels
and sAA. Contrary to our hypothesis, a significant inverse correlation was found between
baseline cortisol levels and baseline sAA levels [r (42) = -.26, p=.041]. As baseline cortisol
levels increased, baseline sAA levels decreased.

Alpha-Amylase
Figure 2 presents the sAA results as a function of group, condition, and time. We
hypothesized that the GAD group would not have an elevated baseline sAA compared to the
non-clinical group. The analysis indicated no significant main effect between the non-clinical
(M=24.480, SD=28.936) and GAD groups (M=17.428, SD=19.964) for baseline sAA levels [F
(1,44) = .999, p=.324] (see Table 5). We also hypothesized there would be a greater sAA
response in GAD compared to non-clinical groups. There were no significant differences in the
increases of sAA levels between the non-clinical group for T2 (M=-.0156, SD=32.816) or T3
(M=-1.843, SD=35.417) and GAD groups at T2 [(M=4.547, SD=25.585), F (1,44) = .263
p=.611] or T3 [(M=4.323, SD=28.770), F (1,44) = .508, p=.480]. Also, there was no difference
for sAA responses for condition at T2 [F (1,44) = .533, p=.470] or T3 [F (1,44) = 1.650,
p=.207]. However, there was a marginally significant group by condition interaction for T2
sAA response [F (1,44) = 3.696, p = .062] but not T3 [F (1,44) = .000, p=1] (See Table 5). This
suggests that breaking the groups into stress, no-stress subgroups had some effect on the sAA
response. The non-clinical, non-stress subgroup had a significantly different stress response from
the other three subgroups. Although it was not significant, the GAD, stress condition (M=12.135,
SD=33.320) and the GAD, control condition (M=10.233, SD=27.060) both had elevated sAA
levels T1 to T2 to T3 (see Table 3).
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We hypothesized that there would be no significant correlation between baseline sAA
and BAI or TMAS measures. As predicted there was no significant relationship between baseline
sAA and BAI [r (1,44) = -.111, p = .236] or baseline sAA and TMAS measures [r (1,44) = .-135,
p = .191]. Neither the BAI nor TMAS showed a relationship with baseline sAA measures.

Anxiety Scales
There was a significant main effect for the TMAS [F (3,46) = 12.445, p=.000] according
to group. The GAD group (M=23.864, SD=7.213) showed a significantly higher TMAS score
than the non-clinical group (M=11.667, SD=5.189). We did not include the Beck because we
used it as part of our grouping criteria. However, also as predicted, the BAI and TMAS had a
significant positive correlation [r (44) = .792, p=.000] (see Table 4). The scores of one
questionnaire predicted scores for the other; or as the BAI scores increased, the TMAS scores
increased.
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Section 4: Discussion
The aim of our study was to examine the two stress responses in GAD compared to nonclinical populations using cortisol and sAA measures. Our hypotheses were partially supported.
Although the groups did not differ significantly with regard to baseline cortisol levels, it was in
the hypothesized direction. Moreover, baseline cortisol levels were inversely related to baseline
sAA levels.
Cortisol
We did not find a significant difference between GAD and non clinical groups for
baseline cortisol, however it was in the hypothesized direction. This lack of a relationship has
been found previously by Takahashi et al. (2005) but there are other studies that have also found
a positive relationship between increased baseline cortisol and pathology (Careny, et al., 2007;
Guinjoan, et al., 1995; Vaith, et al., 1994). One reason for our finding may be our
disproportional amount of females in our GAD group (77%). Highly anxious females have been
found to have significantly lower cortisol levels than highly anxious males (Takai, Yamaguchi,
Aragaki, Eto, Uchihashi, Nishikawa, 2007). However, we performed a multivariate general
linear ANOVA with sex as a covariate that determined that sex did not influence our results.
Alternatively, our non-significant finding may be due to diagnostic technique. In our study, the
anxiety group was determined using the M.I.N.I. We did not follow-up with other techniques for
determining GAD. In addition, it is possible that our GAD group was confounded with other
disorders because we only controlled for comorbid anxiety disorders. For example, depression
has been found to be significantly associated with GAD (Kessler et al., 2005). It is also possible
that our GAD group was not GAD. The BAI may not add the same level of anxious individuals
as the M.I.N.I.
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We found a significant group by stress condition interaction, which indicates that our
GAD, stress subgroup had significantly elevated baseline cortisol compared to the other groups.
This was determined with a tukey’s post hoc test of the means. This suggests that the groups
were different at the start of the study and could have altered several of the cortisol comparison
results including the stress-induced cortisol response.
With regard to the stress manipulation, we used a knee replacement surgery clip.
Previous studies (Bosch et al., 2003; Takai et al., 2004, Takai et al., 2007) have employed the
viewing of surgical clips as a method for inducing stress and anxiety. We did find a significant
increase in salivary cortisol levels for the stress condition. Regardless of group, individuals
viewing the knee replacement video displayed greater elevation in salivary cortisol than the
participants in the no-stress condition. This suggests that our stressor caused a cortisol stress
response providing evidence that our stressful video was successful eliciting a stress response.
Behavioral observations supported this conclusion of the knee replacement video as stressful.
For example, several participants showed eye aversion and fidgeting while viewing the video.

Alpha Amylase
With regard to the protein sAA, we found no significant differences between groups on
baseline measures. The null hypothesis was supported in our study and is in line with previous
research regarding basal sAA and GAD (Fisher, Granger, Newman, 2010). We expected this
result because sAA is a response to arousal as it is correlated with the release of epinephrine.
Epinephrine is released in response to stress in the ANS. Although we found that the GAD
group reported greater trait anxiety compared with the non-clinical control participants, there
was no significant difference on sAA levels between the groups contrary to Takai et al. (2004).
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Moreover, sAA did not correlate significantly with any of the self-report measures, yet we found
a significant inverse relationship between baseline cortisol levels and baseline sAA levels. We
are unaware of any previous research that has found this result. The inverse relationship may be
due to our data collection being limited to morning hours. sAA drops to its lowest in the morning
and cortisol peaks at its highest in the morning hours. The diurnal patterns continue to oppose
each other throughout the day. Alternatively, Het, Schoofs, Rohleder, and Wolf (2012) found a
negative correlation between cortisol and negative affect. They also found a positive correlation
between sAA levels and negative affect. They explained that the negative affect of the stressor is
associated with sAA levels then cortisol acts as a “mood buffer” later on. While this is not a
direct inverse relationship it may provide us with insight to our findings. Neither group
experienced an increase in sAA. Therefore it is possible the GAD group entered the study with
negative affect due to everyday stressors of university life causing an up regulation of baseline
cortisol to try to buffer the circular negativity bias associated with anxiety.
There have been a number of studies that have reported no relationship between sAA and
cortisol (Chatterton et al., 1996; Fisher, Granger, Newman, 2010; Nater & Rohleder, 2009;
Schenkels, Veerman, Nieuw Amerongen, 2005, Strahler et al., 2010, van Veen et al., 2008). van
Veen et al. (2008) did not find significant differences for cortisol levels, but did find significant
differences between baseline sAA levels and diurnal sAA levels between SAD and control
groups. They suggested an imbalance in the two stress systems. It may be that GAD does not
evoke autonomic arousal at baseline. Fisher, Granger, and Newman, 2010 reported that the
DSM-IV removed the autonomic activity (e.g. sweating, increased heart rate, etc.) from its
criteria for generalized anxiety (DSM-IV, 1994) because there was trouble replicating autonomic
function in a clinical setting. In concordance to this, they found no significant difference between
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GAD and controls for baseline sAA levels. They sampled 107 participants and divided them
using the MINI into Control (n=62), GAD (n=21), and GAD comorbid (n=24). They measured
sAA levels at baseline and post stressful video. They found that the GAD and GAD comorbid
group act very differently in terms of their sAA response. Of their GAD cormorbid group, 15
were depressive disorders. They provided evidence that GAD shows diminished physiological
flexibility and that comorbidity must be taken into account when examining sympathetic arousal
of anxiety disorders. It is possible that our lack of account for depressive disorders skewed our
results. In the same way, Fisher & Newman (2013) reported diminished HR responses and
concluded suppression of adrenergic sympathetic response in GAD. Therefore, it is possible that
GAD individuals exhibit a diminished SAM pathway response and an over active HPA axis.
Granted that both the SAM pathway and HPA axis both start in the hypothalamus, it may be that
in GAD individuals the hypothalamus responds to minor stressors as “chronic” therefore
activating HPA axis to acute stress as opposed to the SAM pathway in GAD. Or there may be a
blocked system that causes a one-way activation path to the HPA axis for all stressors. This
would consequently deprive the SAM pathway of resources and activation reducing the amount
of alpha-amylase produced, but increase cortisol. Because our groups did not show a sAA
response, our data neither supports nor refutes this hypothesis. Future studies should investigate
this further. It is also possible that general academics or the process of coming in for an
unfamiliar experiment causes activation of one stress response but not the other. Further studies
are warranted to understand the relationship between the two stress response systems in GAD.
We also hypothesized that the stress manipulation would generate greater levels of sAA
in the GAD group compared to the non-clinical participants. This hypothesis was not supported.
However, Takai et al (2004) reported the use of a stressful video to consequently increase sAA
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levels, but these levels returned to baseline by the end of the video watching. They took saliva
samples throughout the video manipulation. In our study, saliva samples were collected
immediately after the 6 minute video viewing and 30 minutes later.

BAI vs TMAS
We found a significant positive correlation between the state and trait measures of
anxiety. This was an expected finding and it is consistent with other researchers (Gould et al.,
1984; Hanton et al., 2002). The significant correlation between the BAI and TMAS is interesting
because they are supposed to measure state and trait anxiety respectively. Our results suggest
they may share more similar components than previous thought.

Limitations
Some limitations to the study include methodology, choice of stressor, sample size, and
sample acquisition. First, our sample was a convenience sample. The HPR pool allows for
students to sign up for studies in exchange for class credit. There may have been a bias of
students that were drawn to the title of the study due to personal issues. Likewise, the time
period for participations was limited to the morning hours. This may have influenced the type of
participants for this study. Also sample size was a limiting factor. It was difficult to find 24
people with GAD. We therefore included people who qualified as medium anxiety (score >15)
according to the BAI, which has been used for diagnostic purposes. It was also difficult to find
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24 people that did not have any underlying anxiety problem. Cleaner group delineation may have
yielded richer data and a better understanding regarding this subject matter.
Part of our study that may have been limiting for us was our choice of stressor. Choosing
the surgical video was designed to have the participant view something that would make them
uncomfortable enough to produce a physiological response without having to frighten them or
produce a specific type of anxiety such as a social situation. In those cases for example, we
would no longer be measuring GAD; we would be measuring Phobias or Social Anxiety
Disorder (SAD). This gives us a narrow range of stressor to choose from, but according to our
data the stressor was effective. It is also possible that the video made some people anxious,
because they are scared of surgeries. There is also the possibility that the participants entered the
study nervous and therefore their arousal levels were already elevated.
Finally, it must be noted that the sAA analysis was amended due to equipment issues.
The protocol requires that the sAA substrate solution be warmed for 20 minutes to 37º C in plate
incubator. This is a kinetic assay and the substrate must be warmed in order to facilitate binding.
We did not have a plate incubator, but warmed the solution on a hot plate. We used a
thermometer to gage the temperature of the solution during this 20 minutes time period. It is
plausible that this amended protocol may have influenced our sAA findings.
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Section 5: Future Directions and Conclusion
In the future, this experiment should be replicated with a larger sample, cleaner
diagnostic groupings, and different types of stressors. This would provide insight into the
different ways each anxiety disorder differs with respect to physical and psychological stressors
and the neuroendocrine correlates associated with such an environmental stimulus. Similar to the
Takahasi et al. (2005), repeated sampling of saliva during the stressor would improve upon the
sensitivity of the current study. Finally, incorporating a 37º C plate incubator for analyzing sAA
is also warranted.
In conclusion, we found differences in cortisol response between conditions supporting our
premise that the surgical video was stressful. We found marginal differences in baseline cortisol
between groups, a marginally significant interaction between groups and condition that suggest
that the GAD, treatment subgroup had a greater T2 response than the other subgroups. We found
no significant difference between groups or subgroups that would suggest deviant autonomic
activation. We also found a negative correlation between baseline sAA and cortisol levels. This
provides evidence of opposing diurnal patterns between the two stress response systems. And the
marginally significant effect of baseline cortisol between groups suggests that cortisol may be a
better determinate of stress in GAD. Finally, there was also a significant difference between
groups on the TMAS. This may provide evidence for the TMAS to be used clinically as a
diagnostic tool.
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Table1.
Total Means
N

Mean

Std. Deviation

Age

46

20.609

1.926

Beck

46

12.174

9.379

TMAS

46

17.500

8.717

Cort 1

46

.455

.252

Cort2

46

.533

.368

Cort 3

46

.465

.350

sAA 1

44

20.954

24.825

sAA 2

44

18.666

26.210

sAA 3

44

23.466

24.556

DIFF(Cort2,1)

45

-.005

.547

DIFF(Cort3,1)

45

-.003

.514

DIFF(sAA2,1)

43

2.318

29.076

DIFF(sAA3,1)

43

1.312

31.952

Valid N (listwise)

43
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Table 2.
Non-clinical Group Means
Condition
Age

Beck

TMAS

Cort 1

Cort2

Cort 3

sAA 1

sAA 2

sAA 3

Mean

N

Std. Deviation

Stress

20.583

12

2.644

Non-Stress

20.500

12

1.732

Total

20.542

24

2.186

Stress

6.000

12

4.285

Non-Stess

6.000

12

3.437

Total

6.000

24

3.799

Stress

11.667

12

6.242

Non-Stress

11.667

12

4.163

Total

11.667

24

5.189

Stress

.350383

12

.210

Non-Stress

.420858

12

.147

Total

.385621

24

.181

Stress

.454908

12

.260

Non-Stress

.481992

12

.237

Total

.468450

24

.244

Stress

.369783

12

.202

Non-Stress

.422433

12

.220

Total

.396108

24

.209

Stress

15.654

11

13.379

Non-Stress

33.306

11

37.522

Total

24.480

22

28.936

Stress

13.835

11

23.758

Stress

11.569

11

22.48

Total

12.702

22

22.602

Stress

13.597

11

22.947
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Table 2. Continued
Non-clinical Group Means
Condition

Mean

N

Std. Deviation

Non-Stress

20.723

11

20.415

17.160

22

21.506

.138

12

.339

-.112

11

.341

Total

.018

23

.356

Stress

.090

12

.295

-.079

11

.343

.009

23

.323

12.136

10

33.320

-11.062

11

29.541

-.015

21

32.816

-8.495

10

42.651

4.204

11

28.056

-1.843

21

35.417

Total
DIFF(Cort2,1)

Stress
Non-Stress

DIFF(Cort3,1)

Non-Stress
Total
DIFF(sAA2,1)

Stress
Non-Stress
Total

DIFF(sAA3,1)

Stress
Non-Stress
Total
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Table 3.
GAD Group Means
Condition
Age

Beck

TMAS

Cort 1

Cort2

Cort 3

sAA 1

sAA 2

sAA 3

Mean

N

Std. Deviation

Stress

20.333

12

1.497

Non-Stress

21.100

10

1.792

Total

20.682

22

1.644

Stress

17.667

12

6.125

Non-Stress

20.400

10

11.834

Total

18.909

22

9.033

Stress

23.417

12

7.573

Non-Stress

24.400

10

7.121

Total

23.864

22

7.213

Stress

.644

12

.328

Non-Stress

.395

10

.197

Total

.531

22

.298

Stress

.778

12

.542

Non-Stress

.397

10

.230

Total

.605

22

.463

Stress

.715

12

.5384

Non-Stress

.330

10

.179

Total

.540

22

.451

Stress

14.978

12

15.139

Non-Stress

20.368

10

25.144

Total

17.428

22

19.964

Stress

19.789

12

17.102

Non-Stress

30.438

10

38.603

Total

24.629

22

28.658

Stress

28.645

12

24.489

Non-Stress

31.127

10

29.506
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Table 3. Continued
GAD Group Means
Condition
Total
DIFF(Cort2,1)

DIFF(Cort3,1)

DIFF(sAA2,1)

N

Std. Deviation

29.773

22

26.246

.154

12

.775

Non-Stress

-.252

10

.564

Total

-.030

22

.703

.173

12

.705

Non-Stress

-.244

10

.567

Total

-.016

22

.666

Stress

-.191

12

24.428

10.233

10

27.060

4.547

22

25.585

Stress

-1.448

12

26.433

Non-Stress

11.250

10

31.298

4.323

22

28.770

Stress

Stress

Non-Stress
Total
DIFF(sAA3,1)

Mean

Total
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Table 4.
Table of Correlations
TMAS
Beck

Pearson Correlation

.007

-.111

.000*

.480

.236

46

46

44

Pearson Correlation

.185

-.135

Sig. (1-tailed)

.109

.191

46

44

N

N
Cort T1

sAA T1

.729

Sig. (1-tailed)

TMAS

Cort 1

Pearson Correlation

-.265

Sig. (1-tailed)

.041*

N

44
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Table 5.
Tests of Between-Subjects Effects
Type III Sum of
Source
Corrected Model

Dependent Variable

Error

Sig.

3

538.807

12.628

.000*

.549

3

.183

3.196

.034*

c

3

748.392

1.225

.314

1.438

d

3

.479

1.595

.206

1.200

e

3

.400

1.498

.230

sAAT2-T1

3635.488

f

3

1211.829

1.483

.234

sAAT3-T1

2133.008

g

3

711.003

.681

.569

TMAS

13486.556

1

13486.556

316.091

.000*

Cort 1

8.976

1

8.976

156.846

.000*

sAA 1

19674.803

1

19674.803

32.195

.000*

CortT2-T1

.001

1

.001

.003

.959

CortT2-T1

.001

1

.001

.003

.954

sAAT2-T1

330.158

1

330.158

.404

.529

sAAT3-T1

81.151

1

81.151

.078

.782

TMAS

1615.633

1

1615.633

37.866

.000*

Cort 1

.165

1

.165

2.875

.098

sAA 1

610.375

1

610.375

.999

.324

CortT2-T1

.086

1

.086

.286

.596

CortT3-T1

.040

1

.040

.149

.702

sAAT2-T1

214.940

1

214.940

.263

.611

sAAT3-T1

530.673

1

530.673

.508

.480

TMAS

3.916

1

3.916

.092

.764

Cort 1

.100

1

.100

1.747

.194

sAA 1

1240.066

1

1240.066

2.029

.162

CortT2-T1

1.358

1

1.358

4.519

.040*

CortT3-T1

1.056

1

1.056

3.955

.054

sAAT2-T1

435.988

1

435.988

.533

.470

sAAT3-T1

1723.723

1

1723.723

1.650

.207

TMAS

1.527

1

1.527

.036

.851

Cort 1

.249

1

.249

4.351

.044*

sAA 1

309.502

1

309.502

.506

.481

CortT2-T1

.028

1

.028

.092

.763

CortT3-T1

.115

1

.115

.430

.516

sAAT2-T1

3020.872

1

3020.872

3.696

.062

sAAT3-T1

6.599E-7

1

6.599E-7

.000

1.000

TMAS

1663.998

39

42.667

CortT3-T1

Group * Condition

F

b

CortT2-T1

Condition

Mean Square

1616.420

TMAS

sAA 1

Group

df
a

Cort 1

Intercept

Squares

2245.176
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Table 5. Continued
Tests of Between-Subjects Effects
Type III Sum of
Dependent Variable

Total

Corrected Total

Squares

df

Mean Square

Cort 1

2.232

39

.057

sAA 1

23833.556

39

611.117

CortT2-T1

11.720

39

.301

CortT3-T1

10.416

39

.267

sAAT2-T1

31873.556

39

817.271

sAAT3-T1

40746.316

39

1044.777

TMAS

17033.000

43

Cort 1

12.121

43

sAA 1

45820.348

43

CortT2-T1

13.158

43

CortT3-T1

11.616

43

sAAT2-T1

35740.265

43

sAAT3-T1

42953.342

43

TMAS

3280.419

42

Cort 1

2.780

42

sAA 1

26078.732

42

CortT2-T1

13.158

42

CortT3-T1

11.616

42

sAAT2-T1

35509.045

42

sAAT3-T1

42879.325

42

F

Sig.

a. R Squared = .493 (Adjusted R Squared = .454)
b. R Squared = .197 (Adjusted R Squared = .136)
c. R Squared = .086 (Adjusted R Squared = .016)
d. R Squared = .109 (Adjusted R Squared = .041)
e. R Squared = .103 (Adjusted R Squared = .034)
f. R Squared = .102 (Adjusted R Squared = .033)
g. R Squared = .050 (Adjusted R Squared = -.023)
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Figure 1. Cortisol Time Series (T) Means
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Figure 2. sAA Time Series (T) Means
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Figure 3. Difference in Cortisol T2-T1 (Group*Condition)
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